HCQ Has 'No Benefit' for Covid-19, Recruiting of Patients For Trial to be Stopped: Oxford University - NEWS E HUB

Slider Widget

Saturday, 6 June 2020

HCQ Has 'No Benefit' for Covid-19, Recruiting of Patients For Trial to be Stopped: Oxford University


Hydroxychloroquine, decades-old malaria and rheumatoid arthritis drug, has been touted as a possible treatment for the new coronavirus by high profile figures.

No comments:

Post a Comment